次全视网膜冷凝联合睫状体冷凝治疗新生血管性青光眼

摘要

目的评价次全视网膜冷凝联合睫状体冷凝治疗新生血管性青光眼的效果。方法回顾分析65例行次全视网膜冷凝联合睫状体冷凝治疗的新生血管性青光眼病例。结果术后随访7mo～4a，50例眼压控制在1.30～2.80kPa，有效率达84.4%，优于睫状体冷冻术，主要并发症为角膜水肿、球结膜水肿、前房纤维素性渗出、低眼压等。结论次全视网膜冷凝联合睫状体冷凝是治疗新生血管性青光眼比较有效的方法。%Objective　To evaluate the effect of the retina cryoautery combined with ciliary body cryoautery against neovascular glaucoma.Methods　Sixty-five cases of neovascular glaucoma treated by the retina cryoautery combined with ciliary body cryoautery were prospectively analysed.Results　In the follow-up examination of 7mo～4a, fifty cases were controlled from 1.30kPa to 2.80kPa, the retina cryoautery combined with ciliary body cryoautery against neovascular glaucoma had successful outcomes in 84.4%, and was prior to ciliary body cryoautery. Its complications were mainly cornea edema, conjunctiva edema, fibrinous inflammation in anterior chamber, hypotension etc.Conclusion　The retina cryoautery combined with ciliary body cryoautery against neovascular glaucoma is an effective treatment.